GILEAD SCIENCES, INC. (GILD)

SEC filing

GILEAD SCIENCES, INC.

GILD · CIK 882095

4 · Sep 11, 2026 · Director, Chairman & CEO O'Day Daniel Patrick exercised options for 17.56K shares; reported 4,230 shares

Director, Chairman & CEO O'Day Daniel Patrick exercised options for 17.56K shares; reported 4,230 shares

FORM 4

xslF345X06/wk-form4_1789165629.xmlSEC.gov

Graphics and non-inline formats (not embedded below).